Silvia Taylor of Novavax details how the company leverages its expertise in vaccine development to build partnerships across ...

Phase 2b efficacy trial in South Africa completes enrollment U.S./Mexico Phase 3 trial expected to begin in the coming weeks GAITHERSBURG, Md., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: ...

Jan 20 (Reuters) - Novavax ‌said on Tuesday it signed a licensing ‌agreement allowing Pfizer access to its technology that boosts immune responses to vaccines for use in up to two infectious diseases, ...

After opening the year projecting COVID vaccine sales of between $800 million and $1 billion, Novavax has slashed its estimate to a range of $275 million to $375 billion. (Photo by Patrick van Katwijk ...

Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical Officer Dr. Walker will continue advancing Novavax's R&D efforts with ...

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 11.3% in the afternoon session after documents revealed ...

Vaccine maker Novavax inked a three-year supply deal to include its adjuvant in vaccine research backed by an arm of the Bill & Melinda Gates Foundation. As part of the accord, Novavax will provide ...

First, a quick summary of Novavax's story so far. The vaccine maker's shares soared early in the COVID-19 vaccine race, skyrocketing more than 2,000% in 2020 as investors bet on its vaccine candidate.

Good morning, and welcome to Novavax' First Quarter 2024 Financial Results and Operational Highlights Conference Call. All lines will be in a listen-only mode. [Operator Instructions]. Please note ...

Novavax has brought together its coronavirus vaccine with its expertise in flu to create a candidate that would protect people from both flu and COVID for the season. This could be particularly ...

Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Novavax is a biotechnology company specializing in the ...

GAITHERSBURG, Md., March 30, 2026 /PRNewswire/ -- Novavax, Inc. today announced the appointment of Dr. Robert Walker, MD, as Executive Vice President and Head of Research & Development (R&D). Dr.